microRNAs (miRNAs) are emerging as novel biological targets for medicinal chemists to develop chemical tools for intracellular regulation. In this context, the discovery of small-molecule drugs targeting specific miRNAs and modulating their production or function represents a very promising approach that could be further developed for targeted...
-
December 7, 2017 (v1)Book sectionUploaded on: December 4, 2022
-
October 28, 2020 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
September 25, 2020 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
September 17, 2020 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
May 2016 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
August 27, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
May 31, 2023 (v1)Journal article
Abstract Targeting RNA with small molecules is a major challenge of current medicinal chemistry, and the identification and design of original scaffolds able to selectively interact with an RNA target remains difficult. Various approaches have been developed based on classical medicinal chemistry strategies (fragment‐based drug design, dynamic...
Uploaded on: November 25, 2023 -
March 8, 2022 (v1)Journal articleHighlights of the UCAncer 2021 symposium on multidisciplinary approaches to cancer research Contexte
International audience
Uploaded on: April 23, 2023 -
2022 (v1)Journal article
No abstract available
Uploaded on: February 22, 2023 -
April 2022 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
June 1, 2021 (v1)Journal article
La pandémie inédite liée à la COVID-19, maladie émergente causée par le SARS-CoV-2 (coronavirus 2 du syndrome respiratoire aigu sévère), touche tous les continents. La lutte contre cette infection passe par des mesures d'hygiène strictes, ainsi que le développement de vaccins et de nouvelles thérapies. La chémobiologie, domaine de recherche à...
Uploaded on: December 4, 2022 -
November 2022 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
April 2022 (v1)Journal articleHighlights of the UCAncer 2021 symposium on multidisciplinary approaches to cancer research Contexte
International audience
Uploaded on: February 16, 2024 -
June 2021 (v1)Journal article
Natural tyrosinase inhibitors from herbal plants are promising therapeutic agents for skincare and cosmetic products. Natural curcuminoids exhibit weak antityrosinase properties. The structural modification of curcumin, the major curcuminoid from Curcuma longa, gave 14 analogues. The tyrosinase inhibitory activity of the natural curcuminoids...
Uploaded on: December 4, 2022 -
December 31, 2018 (v1)Journal article
Targeting biologically relevant noncoding RNAs using small molecules is currently one of the major challenges of medicinal chemistry but holds a great potential for future therapeutic applications. In this context, oncogenic microRNAs represent a particularly promising target, and various examples of RNA binders have been reported as inhibitors...
Uploaded on: December 4, 2022 -
June 10, 2021 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
January 2020 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
January 2020 (v1)Journal article
International audience
Uploaded on: February 22, 2023 -
November 14, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
February 10, 2014 (v1)Journal article
The human immunodeficiency virus type-1 (HIV-1) Tat protein stimulates transcriptional elongation. Tat is involved in the transcription machinery by binding to the transactivation response region (TAR) RNA stem-loop structure, which is encoded by the 5' leader sequence found in all HIV-1 mRNAs. Herein, we report the rational design, synthesis,...
Uploaded on: March 26, 2023 -
March 23, 2022 (v1)Journal article
2-deoxystreptamine (2-DOS) conjugates with artificial nucleobases were designed and synthesized to inhibit pre-miR-372 processing into oncogenic miRNA and were discovered to be promising inhibitors when compared to their neomycin counterpart.
Uploaded on: December 4, 2022 -
2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022